Declutter, Organize, Optimize: A Thingless Path to Creativity

This project explores the connection between material possessions, physical clutter and the optimization of one’s personal creativity in their creative environment. It first includes a review of the book The Life-Changing Magic of Tidying Up: The Japanese Art of Decluttering, by Marie Kondo by looking at her methods through the lens of the creative process. The project then documents my personal process of decluttering and optimizing my living space. The project includes some ideas from prior research in the field combined with personal reflections on how the optimization of a physical space can improve one’s creative productivity, creative thinking, personal habits, mental and emotional wellbeing and ultimate lifestyle

Wind-tunnel and Piloted Flight Simulator Investigation of a Deflected-slipstream VTOL Airplane, the Ryan VZ-3RY

No abstract availabl

Flight performance of a navigation, guidance, and control system concept for automatic approach and landing of space shuttle orbiter

Unpowered automatic approaches and landings were conducted to study navigation, guidance, and control problems associated with terminal area approach and landing for the space shuttle vehicle. The flight tests were performed in a Convair 990 aircraft equipped with a digital flight control computer connected to the aircraft control system and displays. The tests were designed to evaluate the performance of a navigation and guidance concept that utilized blended radio/inertial navigation with VOR, DME, and ILS as the ground navigation aids. Results from 36 automatic approaches and landings from 11,300 m (37,000 ft) to touchdown are presented. Preliminary results indicate that this concept may provide sufficient accuracy to accomplish automatic landing of the shuttle orbiter without air-breathing engines

Characterisation of nasal devices for delivery of insulin to the brain and evaluation in humans using functional magnetic resonance imaging

This study aimed to characterise three nasal drug delivery devices to evaluate their propensity to deliver human insulin solutions to the nasal cavity for redistribution to the central nervous system. Brain delivery was evaluated using functional magnetic resonance imaging to measure regional cerebral blood flow. Intranasal insulin administration has been hypothesised to exploit nose-to-brain pathways and deliver drug directly to the brain tissue whilst limiting systemic exposure. Three nasal pump-actuator configurations were compared for delivery of 400 IU/mL insulin solution by measuring droplet size distribution, plume geometry, spray pattern and in vitro deposition in a nasal cast. The device with optimal spray properties for nose to brain delivery (spray angle between 30° and 45°; droplet size between 20 and 50 μm) also favoured high posterior-superior deposition in the nasal cast and was utilised in a pharmacological magnetic resonance imaging study. Functional magnetic resonance imaging in healthy male volunteers showed statistically significant decreases in regional cerebral blood flow within areas dense in insulin receptors (bilateral amygdala) in response to intranasally administered insulin (160 IU) compared to saline (control). These changes correspond to the expected effects of insulin in the brain and were achieved using a simple nasal spray device and solution formulation. We recommend that a thorough characterisation of nasal delivery devices and qualitative/quantitative assessment of the administered dose is reported in all studies of nose to brain delivery so that responses can be evaluated with respect to posology and comparison between studies is facilitated

The ASAC Flight Segment and Network Cost Models

To assist NASA in identifying research art, with the greatest potential for improving the air transportation system, two models were developed as part of its Aviation System Analysis Capability (ASAC). The ASAC Flight Segment Cost Model (FSCM) is used to predict aircraft trajectories, resource consumption, and variable operating costs for one or more flight segments. The Network Cost Model can either summarize the costs for a network of flight segments processed by the FSCM or can be used to independently estimate the variable operating costs of flying a fleet of equipment given the number of departures and average flight stage lengths

Pentagon Officials Misled Congress on Transgender Troops by Asserting Falsehoods that DoD’s Own Data Contradict, and by Calling Equal Treatment "Special" Treatment

Two senior Pentagon officials testified on February 27, 2019 before the House Armed Services Subcommittee on Military Personnel in defense of President Trump’s proposed ban on transgender service members, which the Defense Department plans to reinstate once permitted by courts. In their testimony, James N. Stewart, performing the duties of Undersecretary of Defense for Personnel and Readiness, and Vice Admiral Raquel Bono, Director of the Defense Health Agency, misled Congress by asserting falsehoods about readiness and deployment and by saying that applying a single standard of fitness equally to all service members means giving transgender troops “special accommodations.” Their mischaracterizations echoed many of the main points in DoD’s 2018 “Report and Recommendations on Military Service by Transgender Persons,” known as the “Mattis Report.” Both the written and verbal testimony introduced deceptive, erroneous, and false assertions about the ostensible risk that gender dysphoria poses to readiness and deployment and about standards that DoD plans to apply to transgender service members. DoD witnesses deemed gender dysphoria a risk despite the fact that 1) every Service Chief testified in Congress that inclusive policy has not compromised readiness; 2) no evidence supports the assertion; 3) a global medical consensus finds the medical condition is treatable and should not be disqualifying; and 4) DoD’s own data concerning the successful deployment of hundreds of service members with the diagnosis contradict the claim. DoD witnesses defined transgender individuals as a deployment risk and then blamed them for being “unwilling” to adhere to standards written specifically to exclude them from service

Trajectories of depression and anxiety symptom severity during psychological therapy for common mental health problems

BACKGROUND: There is substantial variation in patient symptoms following psychological therapy for depression and anxiety. However, reliance on endpoint outcomes ignores additional interindividual variation during therapy. Knowing a patient's likely symptom trajectories could guide clinical decisions. We aimed to identify latent classes of patients with similar symptom trajectories over the course of psychological therapy and explore associations between baseline variables and trajectory class. METHODS: Patients received high-intensity psychological treatment for common mental health problems at National Health Service Improving Access to Psychological Therapies services in South London (N = 16 258). To identify trajectories, we performed growth mixture modelling of depression and anxiety symptoms over 11 sessions. We then ran multinomial regressions to identify baseline variables associated with trajectory class membership. RESULTS: Trajectories of depression and anxiety symptoms were highly similar and best modelled by four classes. Three classes started with moderate-severe symptoms and showed (1) no change, (2) gradual improvement, and (3) fast improvement. A final class (4) showed initially mild symptoms and minimal improvement. Within the moderate-severe baseline symptom classes, patients in the two showing improvement as opposed to no change tended not to be prescribed psychotropic medication or report a disability and were in employment. Patients showing fast improvement additionally reported lower baseline functional impairment on average. CONCLUSIONS: Multiple trajectory classes of depression and anxiety symptoms were associated with baseline characteristics. Identifying the most likely trajectory for a patient at the start of treatment could inform decisions about the suitability and continuation of therapy, ultimately improving patient outcomes

Impact of deploying multiple point-of-care tests with a 'sample first' approach on a sexual health clinical care pathway. A service evaluation.

OBJECTIVES: To assess clinical service value of STI point-of-care test (POCT) use in a 'sample first' clinical pathway (patients providing samples on arrival at clinic, before clinician consultation). Specific outcomes were: patient acceptability; whether a rapid nucleic acid amplification test (NAAT) for Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG) could be used as a POCT in practice; feasibility of non-NAAT POCT implementation for Trichomonas vaginalis (TV) and bacterial vaginosis (BV); impact on patient diagnosis and treatment. METHODS: Service evaluation in a south London sexual health clinic. Symptomatic female and male patients and sexual contacts of CT/NG-positive individuals provided samples for diagnostic testing on clinic arrival, prior to clinical consultation. Tests included routine culture and microscopy; CT/NG (GeneXpert) NAAT; non-NAAT POCTs for TV and BV. RESULTS: All 70 (35 males, 35 females) patients approached participated. The 'sample first' pathway was acceptable, with >90% reporting they were happy to give samples on arrival and receive results in the same visit. Non-NAAT POCT results were available for all patients prior to leaving clinic; rapid CT/NG results were available for only 21.4% (15/70; 5 males, 10 females) of patients prior to leaving clinic. Known negative CT/NG results led to two females avoiding presumptive treatment, and one male receiving treatment directed at possible Mycoplasma genitalium infection causing non-gonococcal urethritis. Non-NAAT POCTs detected more positives than routine microscopy (TV 3 vs 2; BV 24 vs 7), resulting in more patients receiving treatment. CONCLUSIONS: A 'sample first' clinical pathway to enable multiple POCT use was acceptable to patients and feasible in a busy sexual health clinic, but rapid CT/NG processing time was too long to enable POCT use. There is need for further development to improve test processing times to enable POC use of rapid NAATs